Solna

• Mesalamine administration to prevent development of colorectal cancer in Lynch syndrome Recruiting
  2024-514765-19-01 4 2021-08-12 Lynch syndrome, which is increasing the risk of developing colorectal
• Beamion LUNG-1: A study to test different doses of zongertinib in people with different types of advanced cancer (solid tumours with changes … Recruiting
  2024-511246-39-00 1 2021-07-27 Solid tumours with HER2 aberrations
• FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting
  2024-510579-40-00 9 2020-10-07 Rhabdoyosarcoma
• Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Pembrolizumab in Subjects with Advanced … Recruiting
  2023-509846-36-00 9 2020-05-29 Advanced Solid Tumors
• PiSCATIN - Simvastatin for the treatment of primary sclerosing cholangitis (PSC) - a randomized double-blind, placebo-controlled multicenter … Recruiting
  2024-511053-22-00 4 2020-05-04 Primary sclerosing cholangitis (PSC)
• Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First-in-Human, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to … Recruiting
  2023-509847-29-00 7 2020-04-09 Advanced solid tumors
• Does metformin reduce growth rate of small abdominal aortic aneurysms? Recruiting
  2024-517387-37-00 4 2019-12-12 Small abdominal aortic aneurysm (AAA) under active surveillance; 30-49
• A study evaluating the safety and efficacy of ponatinib for the treatment of recurrent or refractory leukemias or solid tumors in children Recruiting
  2023-509699-41-00 9 2019-11-22 Recurrent or Refractory Leukemias, Lymphomas, and Solid Tumors
• LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting
  2023-508101-24-00 5 2019-08-01 Lymphoblastic lymphoma
• INFORM2 exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high- … Recruiting
  2024-514409-78-01 9 2019-07-26 relapsed / refractory or progressive high risk malignant disease
• Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing - The INSTAR study Recruiting
  2024-515350-25-01 6 2019-04-12 Acute wheezing/bronchiolitis
• ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer Recruiting
  2023-506857-40-00 5 2019-01-08 Prostate Cancer
• A study to compare conventional "salvage" radiotherapy and individualized treatment based on results from PSMA PET/CT assessments in patient … Recruiting
  2023-504917-54-00 5 2018-10-30 Biochemical recurrence after prostate cancer surgery
• Extension Study for Participants in Studies That Include Pembrolizumab Recruiting
  2022-501254-10-00 5 2018-08-24 Advanced tumors
• A modular multi-Basket trial to improve personalized medicine in cancer patients Recruiting
  2024-514238-19-00 4 2018-03-28 Subjects with advanced solid tumour
• Stopping anti-TNF treatment in Crohn's and Colitis patients in remission Recruiting
  2024-513299-17-00 6 2017-05-05 Ulcerative colitis
• Desferal administration to improve the impaired reaction to hypoxia in diabetes (DESIRED) - A randomised, double-blind, placebo-controlled, … Recruiting
  2024-519562-48-00 4 2017-01-12 The study will investigate the effect of deferoxamine on the impaired
• Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) Recruiting
  2023-506987-15-00 9 2016-11-17 Metastatic Castration-Resistant Prostate Cancer
• Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication: BIOMEDE 2.0 Recruiting
  2023-506027-29-00 5 2014-10-01 Children, adolescents and adults with newly diagnosed diffuse intrinsi
• NOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years Recruiting
  2024-518254-16-00 5 2013-03-01 Acute Myeloid Leukemia (Pediatric 0-18 years)
• A phase II trial of 177Lutetium-DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma LuDO-N Ended recruitment
  2023-503684-42-00 4 2026-02-20 Neuroblastoma
• A Study to Compare Risankizumab to Vedolizumab in Adult Subjects With Moderate to Severe Ulcerative Colitis Ended recruitment
  2024-518998-33-00 5 2025-07-23 Ulcerative Colitis
• A Phase 3 Study Comparing BMS-986365 versus Investigator’s Choice of Therapy in Participants with Metastatic Castration-resistant Prostate C … Ended recruitment
  2024-517422-25-00 5 2025-05-22 Metastatic Castration-resistant Prostate Cancer (mCRPC)
• A Phase 3 study to assess the efficacy, safety, and tolerability of itepekimab (anti­IL­33 mAb) in participants with inadequately-controlled … Ended recruitment
  2024-516814-39-00 5 2025-05-20 Chronic rhinosinusitis with nasal polyps

Showing 193–216 of 390 trials